Real-time enrollment status for this ulcerative colitis clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 10:54 AM UTC
| NCT Number | NCT06598943 |
| Recruiting Status | Recruiting |
| Condition | Ulcerative Colitis |
| Phase | PHASE2 |
| Target Enrollment | 143 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | July 30, 2026 (Jul 30, 2026) |
As of September 2, 2026: Clinical trial NCT06598943 is currently recruiting participants. This phase2 study for ulcerative colitis is actively seeking new participants at 46 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06598943 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06598943 was last updated Jul 30, 2026 (July 30, 2026). HelloStudys verifies this status automatically.